Cargando…
Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been identified in China as the etiologic agent of the recent COVID-19 pandemic outbreak. Due to its high transmissibility, this virus quickly spread throughout the world, causing considerable health issues. The scientific communit...
Autores principales: | Romeo, Isabella, Mesiti, Francesco, Lupia, Antonio, Alcaro, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865633/ https://www.ncbi.nlm.nih.gov/pubmed/33530467 http://dx.doi.org/10.3390/molecules26030632 |
Ejemplares similares
-
Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates
por: Coricello, Adriana, et al.
Publicado: (2020) -
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses
por: Artese, Anna, et al.
Publicado: (2020) -
Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach
por: Romeo, Isabella, et al.
Publicado: (2022) -
Functional and druggability analysis of the SARS-CoV-2 proteome
por: Cavasotto, Claudio N., et al.
Publicado: (2021) -
Is the Stalk of the SARS-CoV-2 Spike Protein Druggable?
por: Pipitò, Ludovico, et al.
Publicado: (2022)